Spissu A, Congia S, Piccardi M P, Fadda F, Mangoni A, Gessa G L
Psychopharmacology (Berl). 1980;71(1):7-9. doi: 10.1007/BF00433245.
The effect of tiapride on HVA and 5-HIAA levels in the CSF drawn at pneumoencephalography (PEG) was studied. Five consecutive 5 ml fractions of CSF were drawn from control and tiapride-treated subjects. In both groups, a linear increase in HVA concentrations was found between the first and subsequent fractions. On the contrary, no significant difference in 5-HIAA concentrations was found in sequential CSF samples. Tiapride increased the mean HVA concentrations and caused a steeper caudocranial gradient of this metabolite but failed to modify 5-HIAA concentrations. The results suggest that tiapride blocks dopamine (DA) receptors and increases DA synthesis.
研究了舒必利对气脑造影(PEG)时抽取的脑脊液中高香草酸(HVA)和5-羟吲哚乙酸(5-HIAA)水平的影响。从对照组和舒必利治疗组受试者中连续抽取5个5毫升的脑脊液样本。在两组中,均发现首个样本与后续样本之间HVA浓度呈线性增加。相反,在连续的脑脊液样本中未发现5-HIAA浓度有显著差异。舒必利增加了平均HVA浓度,并导致该代谢产物出现更明显的尾颅梯度,但未能改变5-HIAA浓度。结果表明,舒必利阻断多巴胺(DA)受体并增加DA合成。